Generics 77

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Voriconazole manufacturers

77 products found

Filters

77 products found

voriconazole

Injection, lyophilized 200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, Greece
Unavailable markets
Kosovo
Manufacturer #298

Manufacturer usually replies in 3 days

voriconazole

Vials, injection 10 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #419

Manufacturer usually replies in 3 days

voriconazole

Solution for infusion 200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Estonia , Iraq , Latvia , Libya , Lithuania , Vietnam
Manufacturer #2346

Manufacturer usually replies in 7 days

voriconazole

Powder and solvent for solution for infusion 200 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply, Distribution only
Comments
Dossier availability date: Q1 2024
Manufacturer #1377
A pharmaceutical manufacturer based in the EU that has been active in 40+ countries selling its products in Europe, the Middle East, North America, Africa, and Asia for 200+ years. Key production lines are Rx, OTC, nutraceuticals, and medical devices. The company's production lines are GMP-compliant. Main dosage forms include solids, liquids, semi-solids, and sterile forms.

Manufacturer usually replies in 8 days

voriconazole

Vials, injection 200mg/vial

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #651

Manufacturer usually replies in 6 days

voriconazole

Vials, injection 200mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #623

Manufacturer usually replies in 9 days

voriconazole

Powder for solution for infusion 200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam , United Arab Emirates , Egypt , China , Chile , Algeria , United States , Cambodia , Canada
Registered in
United Kingdom , Denmark , Italy
Manufacturer #17548
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in Europe, North America, and Asia for 100+ years. Main therapeutic areas include gastroenterology, anti-infectious drugs, inflammation and pain, and nutraceuticals. The main dosage forms are injectable, oral, and topical. They are produced in cGMP-compliant manufacture.

Manufacturer usually replies in 11 days

voriconazole

Vials, injection 200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17703
It began in the 1910s as a supplier of phytopharmaceuticals and plant-based therapeutic products. Since the company's reorganization, they have mostly focused on generic antibiotics with a concentration on sterile items for hospital use. Since then, they have steadily grown their product line and introduced new pharmaceutical goods to the market. It is a well-known provider of sterile pharmaceutical items in the clinic sector, supplying nearly all clinic pharmacies in one of the main markets in Western Europe.

Manufacturer usually replies in 48 days

voriconazole

Vials, injection 200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA
Comments
Storage conditions: Between 15-25°C (59-77°F)
Manufacturer #1187

voriconazole

Tablets 50mg, 200mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom , Spain , Germany , Slovakia , Poland , Czech Republic , Netherlands , Romania
Manufacturer #6978

Manufacturer usually replies in 3 days

voriconazole

Vials, injection 200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Unavailable markets
Bulgaria , Costa Rica , Albania , Bosnia And Herzegovina , Kosovo , Serbia , Slovenia
Manufacturer #361

It is a global player with more than half a century of experience. It has more than 4 facilities to operate from. They have marketing and promotion in more than 20 countries. It exports to more than 50 countries. The only motto is to improve the quality of human life and to provide access to reliable, high-quality products for human health worldwide. It is focused to create its own cadres in every country it operates.

Manufacturer usually replies in 9 days

voriconazole

Tablets, film coated 200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Unavailable markets
Bulgaria , Costa Rica , Vietnam , Albania , Bosnia And Herzegovina , Kosovo , Serbia , Slovenia
Manufacturer #361

It is a global player with more than half a century of experience. It has more than 4 facilities to operate from. They have marketing and promotion in more than 20 countries. It exports to more than 50 countries. The only motto is to improve the quality of human life and to provide access to reliable, high-quality products for human health worldwide. It is focused to create its own cadres in every country it operates.

Manufacturer usually replies in 9 days

voriconazole

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
EU GMP
Manufacturer #12677

Manufacturer usually replies in 4 days

voriconazole

Vials, lyophilized injection 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #15176

Manufacturer usually replies in 5 days

voriconazole

Tablets, orally disintegrating (ODT) 200 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
EU GMP
Manufacturer #12677

Manufacturer usually replies in 4 days

voriconazole

Powder for solution for infusion 200 mg - 30 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, PICS
Manufacturer #2760

Manufacturer usually replies in 5 days

voriconazole

Tablets 50 mg, 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA
Manufacturer #18120

Manufacturer usually replies in 7 days

voriconazole

Vials, lyophilized injection 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS, EU GMP
Manufacturer #2272
The company integrates and applies enormous experience and technology in the field of hospital products. Their goal is to become a global leader in intensive care units and maintain that position. The company's headquarters were established in Europe in 1980ies, and serum production was continuing in a plant in Europe till the end of the 2000s. With a nationwide market share of 50%, it has become one of the leading serum producers. They've already started making the first ready-to-use injections.

Manufacturer usually replies in 7 days

voriconazole

Vials, injection 200mg/30ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #11531

Manufacturer usually replies in 6 days

voriconazole

Tablets 50 mg, 200 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #17643

Manufacturer usually replies in 8 days

Want to view all 77 products? Create your free account today!

Voriconazole belongs to a class of drugs known as azole antifungals. Voriconazole is a broad spectrum, triazole antifungal agent and is indicated in adults and children aged 2 years and above. This medication is used to treat serious fungal infections caused by Scedosporium apiospermum and Fusarium spp. It is also used to treat invasive fungal infections that are generally seen in patients who are immunocompromised. These include invasive candidiasis, invasive aspergillosis, and emerging fungal infections. Voriconazole is advised as a prescription product as well as generic prescription product. Manufacturers market Voriconazole under the Brand name of Vfend. Voriconazole is available in the dosage form of Tablet (Film Coated), Powder (for Suspension and for Solution) and I.V. Injections. Tablet and Powder for Suspension are taken orally, whereas Powder for Solution and Injections are administered intravenously. Voriconazole Tablet are available in dosage strength of 50 mg and 200 mg, and Powder for Suspension is available in 40 mg/1mL and 200 mg. The Voriconazole injections are available in 10 mg/1mL dosage strength. These injections are available as a single dose unpreserved sterile lyophile, which are for single use only and any unused solution should be discarded. Only clear solutions without particles should be used. The Voriconazole tablet and Oral suspension must be taken at least one hour before or after meal, usually every 12 hours. Voriconazole I.V. injection requires reconstitution to 10 mg/mL and subsequent dilution to 5 mg/mL or less prior to administration as an infusion, at a maximum rate of 3 mg/kg per hour over 1 to 2 hours. The diluted I.V. must be administered by intravenous infusion over 1 to 2 hours only and it should not be administered as an IV bolus injection. Voriconazole Tablets should be stored at 15° C to 30° C (59° F - 86° F). Before reconstitution, Powder for Oral Suspension should be stored at 2° C to 8° C (36° F - 46° F) (in a refrigerator). The reconstituted suspension should be stored at 15° C to 30° C (59° F - 86° F). It should not be refrigerated or freeze and the container must be tightly closed. Wholesale Price of Voriconazole The wholesale price of Voriconazole 50 mg oral tablet costs around $ 162.91 for 30 tablets and the lowest available price is $ 1.51 per tablet for 84 tablets (Bottle) at local U.S pharmacies. The per unit cost 200 mg voriconazole oral tablet is around $ 8.02 - $ 37.83 which costs around $ 240.61 for 30 tablets. The per unit price of 200 mg voriconazole intravenous powder for injection is $ 44.23 Voriconazole - Mechanism of Action The primary mode of action of Voriconazole is the inhibition of fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylation, an essential step in fungal ergosterol biosynthesis. Voriconazole binds and inhibits ergosterol synthesis by inhibiting CYP450-dependent 14-alpha sterol demethylase. The inhibition of 14-alpha sterol demethylase results in depletion of ergosterol in fungal cell membrane and thus responsible for the antifungal activity of Voriconazole. Finding Voriconazole Manufacturers and Suppliers Finding an accurate partner in our business is one of the big challenges and to overcome that challenges and to make one’s work easy in finding the accurate and good manufacturer and supplier of Voriconazole one can visit the Pipelinepharma website which helps one in finding the dependable manufacturers and suppliers of Voriconazole. Pipelinepharma, which is a business-to-business (B2B) licensing marketplace for pharmaceutical products, quickly connects owner with the buyer for the business advancement. One can filter the product names in unified search engine by its country, category, therapeutic area, forms, dossier and its status, regulatory filings, approvals, and more.